Lithuania's Biomatter raises $18M Series A for AI enzyme design platform
This story is from 2026-11-12. It is preserved in the archive; the latest stories are on the live feed.
Vilnius-based Biomatter announced on November 12, 2026 an oversubscribed $18 million Series A led by Astanor, with participation from existing investors UVC Partners, Inventure and Metaplanet, to scale its AI enzyme design platform.
Read the full story at The Next Web ↗
Timeline · 2 reports
- 2026-11-12 12:03 · Unite.AI
Biomatter Raises $18M Series A to Expand AI Enzyme Design and Testing - 2026-11-12 09:45 · The Next Web
Lithuania’s Biomatter raises $18M for AI enzyme design